Editorial: Plant and fungal extracts and metabolites in neurotherapy: exploring their pharmacology and potential clinical uses
- PMID: 40395729
- PMCID: PMC12088933
- DOI: 10.3389/fphar.2025.1602574
Editorial: Plant and fungal extracts and metabolites in neurotherapy: exploring their pharmacology and potential clinical uses
Keywords: central nervous system disorders; ethnopharmacology; neuroprotection; phytochemicals; traditional medicine.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Plant and fungal extracts and metabolites in neurotherapy: exploring their pharmacology and potential clinical uses
References
-
- Gao W., Wilson R., Hepgul N., Yi D., Evans C., Bajwah S., et al. (2020). Effect of short-term integrated palliative care on patient-reported outcomes among patients severely affected with long-term neurological conditions: a randomized clinical trial. JAMA Netw. Open 3, e2015061–e2015061. - PMC - PubMed
-
- Hao J., Li Z., Xie L., Yu B., Ma B., Yang Y., et al. (2024). Syringaresinol promotes the recovery of spinal cord injury by inhibiting neuron apoptosis via activating the ubiquitination factor E4B/AKT Serine/Threonine kinase signal pathway. Brain Research 1824, 148684. 10.1016/j.brainres.2023.148684 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
